N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial

Jerome Sarris, Gerard J. Byrne, David Castle, Chad Bousman, Georgina Oliver, Lachlan Cribb, Scott Blair‐West, Vlasios Brakoulias, David Camfield, Carolyn Ee, Suneel Chamoli, Mark J. Boschen, Olivia Dean, Nathan Dowling, Ranjit Menon, Jenifer Murphy, Najwa‐Joelle Metri, Thomas P. Nguyen, Andrew Wong, Rebecca Jordan, Diana Karamacoska, Susan L. Rossell, Michael Berk, Chee H. Ng